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Summary.-The macrophage electrophoretic mobility test described byCaspary and
Field (1971) and modified by Pritchard et al. (1973) was investigated in various
models of cell-mediated immune conditions in the guinea-pig and in cancer in man.
No positive results were obtained in 92 guinea-pig experiments. Only 17 of 154
experiments on 74 patients gave definite positives in experiments with human
cancer and a few positive results were obtained with normal healthy subjects.
THE possibility ofthere being a common
antigen in human tumours detectable by
a cytopherometer test was put forward by
Caspary and Field in 1971. The test is
based on the hypothesis that the inter-
action of sensitized lymphocytes with
specific antigen liberates some material
from the lymphocytes which has the
property of slowing the electrophoretic
migration of normal macrophages. The
macrophages, obtained from the peri-
toneum ofa normal guinea-pig, are used as
an indicator system for this lymphocyte-
antigen interaction. If this phenomenon
does indeed occur, it would have a great
deal of practical importance as the basis
for a diagnostic test for cancer.
We report here our attempts to get the
test to work over a 3-year period.
MATERIALS AND METHODS
Guinea-pigs.-Four different strains of
guinea-pig were used, from a variety of
different sources: (i) Hartley guinea-pigs
from Animal Suppliers Ltd, Roebuck Farm,
Welwyn, Herts; from Redfern, Jason's Farm,
Brenchley, Kent; from Tuck's, LAB Station,
Rayleigh, Essex. Some were obtained from
Professor E. J. Field, MRC Unit, Newcastle.
(ii) Heston Strain 13 guinea-pigs from Fisons,
Holmes Chapel, Cheshire. (iii) Porton guinea-
pigs from Richardson-Taylor, Woodlands,
Tisbury, Wilts. (iv) ICRF guinea-pigs (an
inbred strain) from The Imperial Cancer
Research Institute, Lincoln's Inn Fields,
London. Some pathogen-free guinea-pigs
obtained from Tuck's LAB Station, Rayleigh,
Essex, were also used.
Peritoneal-exudate inducers.-Bayol F.,
Esso; liquid paraffin (heavy) BP from UCH
Pharmacy; liquid paraffin from B.D.H.,
Poole, Dorset, and also from Fison's, Lough-
borough, Leics, and some samples of a special
stock of liquid paraffin from Professor E. J.
Field, MRC Unit, Newcastle.
Macrophage preparation technique.-After
harvesting the peritoneal exudate, 2 different
procedures were used for preparing the
macrophage suspension: (i) The exudate was
centrifuged for 5 min at 350 g. The pellet was
washed in Hanks' solution, then twice in
Medium 199, centrifuging for 5 min at 350g.
(ii) The exudate was centrifuged for 15 min
at 1500 g; the pellet was washed x 3 in
Medium 199, and centrifuged for 10 min at
200g.
For some ofthe experiments the peritoneal
exudate was irradiated to prevent a subse-
quent mixed lymphocyte reaction between
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the lymphocytes in the exudate and the
human lymphocytes, using 130-170 rad from
a 60Co source.
Procedure for incubating lymphocytes, antigen
and macrophages
Several variations were used: (i) The
lymphocytes, macrophages and antigen were
mixed together and allowed to stand at room
temperature for 90 min, as described by
Caspary and Field (1971). (ii) The lympho-
cytes were incubated with antigen for 30 min
at room temperature, then macrophages were
added and all 3 components incubated to-
gether for a further 60 min at room tem-
perature, as demonstrated to us on a visit to
Professor Field's laboratory at Newcastle.
(iii) Variations ofthe above 2-stage incuba-
tion: (a) Pre-incubation of lymphocytes +
antigen at 37°C with subsequent addition of
macrophages and further incubation at 37°C;
(b) pre-incubation at 37°C, and subsequent
incubation at room temperature; (c) pre-
incubation at room temperature, and subse-
quent incubation at 37°C.
(iv) The lymphocytes were incubatred with
antigen for 90 min at 23°C. The mixture was
centrifuged at 1500g, then the supernatant
was incubated with the macrophages for
90 mins at 37°C. (This is the "MOD-MEM"
technique as described by Pritchard et al.,
1973.)
Lymphocyte concentration for cytopherometer
tests.-In different experiments, 0-25, 0 50,
0 75, 1-0 and 2-0 million cells wrere used for
each sample. Freshly collected lymphocytes
were usually used but lymphocytes stored for
24 h at 4°C were also tried.
Antigen concentration for cytopheromneter
tests-.Various antigen concentrations per
3-ml test sample were tried: 33 ,ug, 66 ,ug,
100 yg and 300 jug.
Antigens used.-(a) In animal-model tests:
egg albumin (EA) in experiments with
animals sensitized with EA in complete
Freund's adjuvant (CFA), tuberculin in
animals sensitized with CFA, encephatilogenic
antigen in animals with experimental allergic
encephalitis. (b) In human cancer tests: 2
' common cancer" antigens were used, one
prepared from a secondary liver tumour, one
prepared from 8 pooled human tumours.
Encephalitogenic antigen prepared from
human brain was also used. The method of
preparation was that described by Caspary
and Field (1965) and recommended in their
cancer-diagnostic-test paper (1971). In addi-
tion, 2 samples of "cancer antigen" prepared
in Professor Field's laboratory andgenerously
donated by him were also tried-one crude
preparation and one purified peptide prepara-
tion. Our cancer material was tested by Dr
Caspary in hislaboratory andreported to give
positive results in their hands.
Laboratory ware. Several types of labora-
tory ware were used, and various methods of
preparation oflaboratory ware were tried. In
some experiments only plastic materials were
used throughout-plastic syringes for collec-
tion of exudate, plastic centrifuge tubes,
plastic beakers, plastic pipettes, etc. In other
experiments only siliconized glassware was
used. Inotherexperimentsnewrnon-siliconized
glassware was used. When ordinary labora-
tory glassware was used, various agents for
washing the glassware were tried: Lab-brite,
Teepol, Decon. For some experiments only chromic acid-washed glassware was used.
Source of human lymphocytes. Blood was
collected from patients in the hospital who
had confirmed cancer at the time ofcollection,
and also from patie.-ts who had recently had
their tumours removed. Patients w%Nith a
variety of different cancers were tested, but
most ofthe experiments were done on breast-
cancer patients. The blood was defibrinated
with glass beads and the lymphocytes were
separated on a Ficoll/Triosil gradient. In some
experiments separation of white cells with
Methocel sedimentation was tried.
Measurement ofmacrophage mobilities in the
cytopherometer.-A Zeiss cytopherometer was
used throughout. Only large macrophages
containing several oil droplets were selected
for timing. Timing was carried out according
to the technique ofCaspary and Field (1971).
For all experiments, each cancer patient's
cells were incubated both with and without
antigen and were compared with a control
subject's cells which were incubated both with
and without antigen. Percentage slowing was
calculated as described by Caspary and Field
(1971) but a test was regarded as positive only if the results of cancer cells + antigen were
significantly different from the results of
control cells + antigen at the 500/' level on a
t test.
Macrophage migration inhibition technique. -This was carried out as described by Desai
and Dale (1974).FAILURE TO OBTAIN POSITIVE MEM TESTS
Lymphocyte activation technique. This was
carried out as described by Andjargholi and
Dale (1977).
Reagents. Hanks' solution from Wellcome
Reagents Ltd, Beckenham, Kent. Ovalbamin
from BDH Chemicals Ltd, Poole, Dorset.
Tuberculin (PPD) from Ministry of Agri-
culture, Fish and Food, WAeybridge. Complete
Freund's Adjuvant from Difco Labs. Ltd,
East Molesey, Surrey. Lab-brite from BHC,
Deer Park Road, London. Teepol and Decon
75 from BDH, Poole, Dorset.
RESULTS
Tests with chemically induced slowing of
macrophage mobility
The cells were treated with neuramini-
dase,whichremoves thenegatively charged
sialic acid from the cell surface. The
resulting concentration-effect curves are
shown in the Fig. They were obtained by
2 different operators at an interval of 12
months, using slightly different technical
procedures, and demonstrate that it is
possible to show, reproducibly, quite small
alterations in macrophage electrophoretic
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mobility (MEM). In our hands, then, the
operation of the cytopherometer is not the
cause of the difficulty in repeating Field
and Caspary's work.
Tests in animal models
Before starting to consider the problem
of the "common cancer antigen", we
attempted to calibrate the technique by
using it in well-defined conditions of cell-
mediated immunity in the guinea-pig
(i.e. tuberculin sensitivity, delayed hyper-
sensitivity to ovalbumin, mixed lympho-
cvte reactions and established experi-
mental allergic encephalitis). Ninety-two
experiments were carried out in these
model systems and in none was any
significant slowing seen, even in animal
models in which concomitant positive
results were obtained in the macrophage
TABLE. (1ompari8qon of Res.ult.s of Cyto-
pherometer Tests (Cy) uwith Macrophage-
Migration-inhibition Tests (MMJ1) and
Lymphocyte Activation Tests (LA) on the
Same Animals Sensitized uwith Complete
Freund's Adjuvant
G-p no.
1
2
3
4
,5
6
7
8
0-08 032
UNITS cm3 NEURAMINIDASE
FIG.-The effect of neuramini(iase on the
electrophoretic mobility of macrophages.
Neuraminidase (1V. cholerae, 500 u/ml,
20 ,g protein/ml) incuibated with 10fi
macrophages in 3 ml TC 199 for: 30 min
at 37°C (Operator 1). e 60 min at room
temperature (Operator 2), % slowing of
macrophages calculated from mean migra-
tion time of macrophages treated with
neuraminidase mintus meani migrationi time
of untieated macrophages.
(a
MMII
migra
ind
66%
63%
41%
64%
42%
52%
47%
39%
test:
Ltion
ex
(b) (c)
LA test: CY test:
((dis/min) slowing
(±) 1960 ( )
(+) 3397 (+)
(+) 1936 (-A-)
(+) 3427 (A-)
(A) 945 (-+ )
(+) 3060 (+)
(-) 2501 (+)
-8% (-)
5% (-)
4% (-)
-2% (-)
4% (-)
-6% (-)
-4.5% (-)
-3°, (-)
(a) Results of MMI tests giveor as the migration
in(lex, i.e.
mean migration of test samples x 100
mean migration of control samples
A result was rated only ifthe (difference between
the means of the 6 test samples and the 6 control
samples was significant at the 50o level on a t test.
(b) Results of LA with PPD (10 ug/ml) given as
(lisintegrations per minute (dis/min). Each figure
represents the mean of 6 test samples minus the
mean of 6 control samples.
(c) Results of the cy test given as 00 slowiing with
PPD (300 ,ug/ml) in the test samples as compaied to
control samples without PPD. A result was rate(l +
only if the (lifference between the means of the test
andl cont,rol s;amples was significanit at, the 5% level
on a t test.
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migration inhibition test and lymphocyte
activationl test using the same material
(see Table).
Most of the 92 experiments were
carried out with PPD in guinea-pigs
sensitized with CFA. In 4 experiments a
mixed lymphocyte reaction between 2
inbred strains of guinea-pig (ICRF and
Strain 13) was used to generate the
macrophage-slowing factor. Two experi-
ments were carried out with encephalito-
genic antigen in animals with clear-cut
experimental allergic encephalitis, and 4
with ovalbumin (EA) in animals sensitized
with EA in CFA. No positive results were
ever obtained in any of these animal
models of cell-mediated immunity, al-
though other indicators of cell-mediated
immune reactivity in the animals were
present (e.g. delayed hypersensitivity re-
actions in the skin).
Tests on human cancer patients
Lymphocytes were obtained from 74
different cancer patients. They were tested
in 154 experiments. Normal subjects were
used as controls in 51 experiments, in
addition to the controls omitting antigens
which were, of course, carried out with
each patient. The overall results were as
follows: significant slowing (as determined
by t tests on the differences between
migration times for macrophages with and
without antigen, for P < 0.05) was ob-
tained in only 17/154 experiments. Highly
significant slowing ( < 0-01) was ob-
tained in only 3 of these experiments. Of
the control experiments with normal
subjects, 2 were positive.
In 5 experiments, patients who had
previously given positive results were
tested again after an interval of2-6 weeks,
and all 5 were negative on the second
occasioIn.
DISCUSSION
Before starting on the cytopherometer
tests, the 2 members ofthe team who were
to use the cytopherometer made sure that
they could obtain results with a well-
defined system neuraminidase-treated
macrophages. Neither had any difficulty
obtaining dose-response curves with these
cells.
We tried the cytopherometer test not
only on human cancer cases but also in
animal models of cell-mediated immune
reactions, expecting it to give positive
results in the animal models, because the
test wasloosely based on areportofastudy
on tuberculin-sensitized guinea-pigs
(Diengdoh and Turk, 1968). We considered
that it would be advantageous to include
well-tried animal models in the project in
a parallel study with human cancer. We
felt that this would enable us to compare
the postulated cancer antigen in humans
with known antigens in guinea-pigs and
would make possible a more rigorous test
ofthe hypothesis of a macrophage-slowing
factor released by activated lymphocytes.
When we were unable to obtain positive
results with the first 6 cancer patients and
with the first 12 tuberculin-sensitized
guinea-pigs, we visited the laboratories of
Field and Caspary in Newcastle and later
the laboratory of Pritchard et al. in
Cardiff to watch their experiments in
progress and to discuss details of the
technique. As a result of these discussions
we tried various modifications of the
cytopherometer test. Altogether, we tested
12 different variables separately in the
course of subsequent experiments, in an
attempt to get the test to work. We tried
varying the strain of guinea-pig used to
provide the macrophages, even to the
extent of obtaining some animals from
Professor Field, and later of using patho-
gen-free animals kept in a pathogen-free
environment up till the moment ofkilling.
We tried 4 different sorts of oil for
induction of the peritoneal exudate, in-
cluding a special batch of paraffin oil B.P.
supplied by Professor Field. On advice
from Professor Field that the laboratory-
ware and its cleaning could be of impor-
tance, we tried 4 different types of
cleaning agents for the glassware (see
Methods). We tried using only siliconized
glass. At one stage we used only plastic
material throughout the procedures. WeFAILURE TO OBTAIN POSITIVE MEM TESTS 549
tried 2 different sorts of tissue culture
medium obtained from several different
suppliers (including the supplier used by
Field). We tried buffering thetissue culture
medium used with hepes buffer, and
buffering with bicarbonate. (Peritoneal
exudates prepared with many of these
variations were used concomitantly in
macrophage migration experiments which
were being carried out in the laboratory as
part of another project (Desai and Dale,
1974); without exception the macrophages
so prepared gave good results in this other
project, but gave negative results in the
cytopherometer test.) We tried varying
the details of the incubation procedure
involving lymphocytes, antigen and macro-
phages, and we tried varying the dose of
antigen and the number of lymphocytes
used (see Methods).
With all these variations we obtained
only 17 clear positives in 154 experiments
on 74 cancer patients. Five of the patients
who gave positive tests were tested 2
weeks or so afterwards, and all gave
negative results in these repeat tests. We
obtained occasional positives on healthy
control subjects.
We disagree with the methods of assess-
ing positive results put forward by
Pritchard et al. (1973), in which readings
are accumulated in 2 columns, "slow" and
"fast", and if 10 "slow" readings are
accumulated first, they and they only are
averaged and used in the calculation of
percentage slowing. We are of the opinion
that it is not justifiable to discard the
remaining readings in this fashion. If it
had been clearly shown that there was a
particular population of"slowable" macro-
phages in a larger population of "un-
slowable" cells, then this procedure might
possibly be justified, but this is not the
case. In our experiments, we only accepted
a result as positive if the mean of the
results with the test samples was signi-
ficantly different from the mean of the
control samples' results at the 5 / level
on a t test. But even when we compared
Pritchard's method of assessing positive
results with our method, on the same
materials, it only marginally increased the
number of tests which were rated as
positive.
Our conclusion is that though there may
be a macrophage-slowing factor released
from antigen-stimulated lymphocytes
under some circumstances, the test as
described by Caspary and Field (1971) and
Pritchard et al. (1973) is not applicable as
an experimental tool for cell-mediated
immune reactions in the guinea-pig or as
a diagnostic test for cancer in man.
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